植入物与双膦酸盐：2012年从业者指南 - Suppr

Suppr

超能文献

Implants and biphosphonates: 2012 guidelines for practitioners.

作者信息

Ruhin B

出版信息

Rev Stomatol Chir Maxillofac Chir Orale. 2013 Feb;114(1):1-3. doi: 10.1016/j.revsto.2012.12.009. Epub 2013 Jan 30.

DOI:10.1016/j.revsto.2012.12.009

PMID:23711209

Abstract

摘要

相似文献

Implants and biphosphonates: 2012 guidelines for practitioners.

Rev Stomatol Chir Maxillofac Chir Orale. 2013 Feb;114(1):1-3. doi: 10.1016/j.revsto.2012.12.009. Epub 2013 Jan 30.

[Implants and biphosphonates: 2012 guidelines for practitioners].

Rev Stomatol Chir Maxillofac Chir Orale. 2013 Feb;114(1):e1-3. doi: 10.1016/j.revsto.2012.12.005. Epub 2013 Jan 30.

FPIN's clinical inquiries. Risks of bisphosphonate use.

Am Fam Physician. 2013 Nov 15;88(10):697, 702.

Preventing medication-related osteonecrosis of the jaw.

BMJ. 2019 May 8;365:l1733. doi: 10.1136/bmj.l1733.

[Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].

Clin Calcium. 2014 Mar;24(3):407-15.

[Prevention and treatment of bisphosphonate-induced jaw bone osteonecrosis. II].

Fogorv Sz. 2014 Sep;107(3):106-7.

Bisphosphonate holidays.

Drug Ther Bull. 2021 Mar;59(3):35-36. doi: 10.1136/dtb.2020.000057.

What do you really need to know about bisphosphonates?

Gen Dent. 2018 Mar-Apr;66(2):23-26.

[Osteonecrosis of the jaw associated with oral treatment with ibandronate].

An Sist Sanit Navar. 2011 Sep-Dec;34(3):489-91. doi: 10.4321/s1137-66272011000300016.

Zoledronic acid and osteonecrosis of the jaw: incidence varies with use.

Gen Dent. 2011 Sep-Oct;59(5):330-2.

引用本文的文献

Osteonecrosis Mandibular Extended to Bisphosphonates: A Very Rare Extensive Case.

Cureus. 2020 Mar 26;12(3):e7428. doi: 10.7759/cureus.7428.

Bisphosphonate treatment and dental implants: A systematic review.

Med Oral Patol Oral Cir Bucal. 2016 Sep 1;21(5):e644-51. doi: 10.4317/medoral.20920.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Implants and biphosphonates: 2012 guidelines for practitioners.

Rev Stomatol Chir Maxillofac Chir Orale. 2013 Feb;114(1):1-3. doi: 10.1016/j.revsto.2012.12.009. Epub 2013 Jan 30.

[Implants and biphosphonates: 2012 guidelines for practitioners].

Rev Stomatol Chir Maxillofac Chir Orale. 2013 Feb;114(1):e1-3. doi: 10.1016/j.revsto.2012.12.005. Epub 2013 Jan 30.

FPIN's clinical inquiries. Risks of bisphosphonate use.

Am Fam Physician. 2013 Nov 15;88(10):697, 702.

Preventing medication-related osteonecrosis of the jaw.

BMJ. 2019 May 8;365:l1733. doi: 10.1136/bmj.l1733.

[Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].

Clin Calcium. 2014 Mar;24(3):407-15.

[Prevention and treatment of bisphosphonate-induced jaw bone osteonecrosis. II].

Fogorv Sz. 2014 Sep;107(3):106-7.

Bisphosphonate holidays.

Drug Ther Bull. 2021 Mar;59(3):35-36. doi: 10.1136/dtb.2020.000057.

What do you really need to know about bisphosphonates?

Gen Dent. 2018 Mar-Apr;66(2):23-26.

[Osteonecrosis of the jaw associated with oral treatment with ibandronate].

An Sist Sanit Navar. 2011 Sep-Dec;34(3):489-91. doi: 10.4321/s1137-66272011000300016.

Zoledronic acid and osteonecrosis of the jaw: incidence varies with use.

Gen Dent. 2011 Sep-Oct;59(5):330-2.

引用本文的文献

Osteonecrosis Mandibular Extended to Bisphosphonates: A Very Rare Extensive Case.

Cureus. 2020 Mar 26;12(3):e7428. doi: 10.7759/cureus.7428.

Bisphosphonate treatment and dental implants: A systematic review.

Med Oral Patol Oral Cir Bucal. 2016 Sep 1;21(5):e644-51. doi: 10.4317/medoral.20920.